web analytics
0.3 C
Munich
Sunday, December 4, 2022

TAG

NWBO

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Red Hot as Positive top-line Data in DCVax®-L Phase 3 trial for Glioblastoma is Picked Up by Mainstream Press

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is rocketing northbound recently surpassing the $1.25 mark on record volume after the Company announced positive top-line results from...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Major Breakout Northbound as Dr. Linda Liau Set to Give Presentation on Murcidencel at the Society for Neuro-Oncology Conference...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is making a powerful move northbound out of its trading range ($0.60 - $0.80) that it has maintained since...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Heats Up as DCVax®-L Proves Safe & Effective While Sawston Facility Applies for Commercial Manufacturing License for Cellular Therapies

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) has made a significant move northbound out of the trading channel where it was trading for the past few...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Looking to Breakout After Phase 3 Clinical Trial of DCVax®-L for GBM Showed Improved Overall Survival & Favorable Safety...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is looking to break north over $0.74 out its current trading channel after recently being decimated due to Adam...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Coming Back After Major Short Attack While Biotech Reports Primary and Secondary Endpoints Met for DCVax®-L with Excellent Safety...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is moving northbound once again after a major short attack with at least 15 million shares sold short decimated...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Bull Run as Biotech Set to Release Phase III Top Line Data for DCVax®-L May 10 / Dr. Linda...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is tearing up the charts making a powerful run northbound easily eclipsing the $1.50 mark where the stock had...

Latest news